Health-related quality of life of the general population during the COVID-19 Omicron outbreak in China: a nationwide survey

The coronavirus disease 2019 (COVID-19) crisis prompted swift policy changes. On December 7, 2022, China substantially relaxed its COVID-19 control measures, marking a shift away from the dynamic zero-COVID policy. This policy change was followed by a rapid nationwide surge in Omicron infections, with potential implications for population health-related quality of life (HRQoL). This study aimed to compare population-level HRQoL across three survey periods following the change in China’s COVID-19 policy and to examine factors associated with the EQ-5D-5 L index within each survey period. We conducted three independent cross-sectional surveys in mainland China on December 21, 2022-January 5, 2023; January 14-February 13, 2023; and May 23-June 4, 2023, recruiting different participants in each period using snowball sampling. HRQoL was assessed using the EQ-5D-5 L index and EQ visual analogue scale (EQ-VAS). Differences across periods were assessed using the Kruskal-Wallis test with pairwise Mann-Whitney U tests. The period-specific two-part regression models were applied: logistic regression for full health (index = 1) versus less than full health (index < 1), followed by gamma-log generalized linear models (GLM) of disutility (1-index) among participants with index scores < 1. Among 2,406 participants, mean EQ-5D-5 L index scores were 0.838, 0.922, and 0.927, and mean EQ-VAS scores were 74.732, 81.418, and 81.341 across the three survey periods, respectively. Full health was reported by 22.3%, 47.0%, and 53.0% of participants, respectively, with fewer problems reported in most EQ-5D-5 L dimensions in the second and third periods. Respiratory symptoms were the most common symptoms across all periods. In two-part regression analyses, absence of symptoms was consistently associated with higher odds of full health, while first-time COVID infection was associated with greater disutility among those reporting less than full health. Population-level HRQoL was lower in the first survey period than in the second and third, with no significant difference between the latter two periods. Absence of symptoms was consistently associated with higher odds of full health, whereas first-time infection was associated with greater disutility among respondents with less than full health. These findings underscore the importance of symptom burden and the period-specific nature of factors associated with HRQoL during changing pandemic conditions.

Authors

Institutions

Publication Details

Journal
BMC Health Services Research
Published
2026-11-21
DOI
https://doi.org/10.1186/s12913-026-16136-z
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Health-related quality of life of the general population during the COVID-19 Omicron outbreak in China: a nationwide survey

Zhuxin Mao, Xuejing Jin, Jan J.V. Busschbach, Weidong Huang et al.
BMC Health Services Research
Health Systems, Economic Evaluations, Quality of Life
article

Health-related quality of life of the general population during the COVID-19 Omicron outbreak in China: a nationwide survey

Zhuxin Mao, Xuejing Jin, Jan J.V. Busschbach, Weidong Huang, Yifan Ding, Gengliang Bai, Tiantian Zhang, Hongchao Li, Pei Wang, Zhihao Yang
article en

Abstract

The coronavirus disease 2019 (COVID-19) crisis prompted swift policy changes. On December 7, 2022, China substantially relaxed its COVID-19 control measures, marking a shift away from the dynamic zero-COVID policy. This policy change was followed by a rapid nationwide surge in Omicron infections, with potential implications for population health-related quality of life (HRQoL). This study aimed to compare population-level HRQoL across three survey periods following the change in China’s COVID-19 policy and to examine factors associated with the EQ-5D-5 L index within each survey period. We conducted three independent cross-sectional surveys in mainland China on December 21, 2022-January 5, 2023; January 14-February 13, 2023; and May 23-June 4, 2023, recruiting different participants in each period using snowball sampling. HRQoL was assessed using the EQ-5D-5 L index and EQ visual analogue scale (EQ-VAS). Differences across periods were assessed using the Kruskal-Wallis test with pairwise Mann-Whitney U tests. The period-specific two-part regression models were applied: logistic regression for full health (index = 1) versus less than full health (index < 1), followed by gamma-log generalized linear models (GLM) of disutility (1-index) among participants with index scores < 1. Among 2,406 participants, mean EQ-5D-5 L index scores were 0.838, 0.922, and 0.927, and mean EQ-VAS scores were 74.732, 81.418, and 81.341 across the three survey periods, respectively. Full health was reported by 22.3%, 47.0%, and 53.0% of participants, respectively, with fewer problems reported in most EQ-5D-5 L dimensions in the second and third periods. Respiratory symptoms were the most common symptoms across all periods. In two-part regression analyses, absence of symptoms was consistently associated with higher odds of full health, while first-time COVID infection was associated with greater disutility among those reporting less than full health. Population-level HRQoL was lower in the first survey period than in the second and third, with no significant difference between the latter two periods. Absence of symptoms was consistently associated with higher odds of full health, whereas first-time infection was associated with greater disutility among respondents with less than full health. These findings underscore the importance of symptom burden and the period-specific nature of factors associated with HRQoL during changing pandemic conditions.

BMC Health Services Research
Nanjing University of Chinese Medicine (CN), Guiyang Medical University (CN), University of Antwerp (BE), Harbin Medical University (CN), Jinan University (CN), China Pharmaceutical University (CN), Beijing University of Chinese Medicine (CN), Fudan University (CN), Erasmus MC (NL)
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon